Form 4: Viatris Inc. Executive Brian Roman Reports Stock Transactions
SEC Form 4
Global General Counsel Brian Roman reports acquisition and disposal of Viatris Inc. stock and derivative securities related to vesting of restricted stock units and performance restricted stock units.
Summary
- On March 5, 2024, Brian Roman, Global General Counsel of Viatris Inc., filed a Form 4 detailing changes in beneficial ownership of Viatris stock.
- The transactions primarily involve the vesting and settlement of performance restricted stock units (PRSUs) and restricted stock units (RSUs) granted in previous years.
- Roman acquired shares through the vesting of PRSUs and RSUs, and simultaneously disposed of shares to cover tax liabilities associated with these vestings.
- The transactions occurred between March 2, 2024, and March 4, 2024.
- After these transactions, Roman directly owns 157,142 shares of Viatris common stock and 70,085 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an executive, with no inherent positive or negative sentiment.
Future Outlook
Future vesting dates for previously granted RSUs are scheduled for March 3, 2025, March 3, 2026, March 4, 2025, March 4, 2026 and March 4, 2027.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions, which are closely monitored by investors.
Comparison to Industry Standards
- Executive compensation packages often include stock and option awards to align management interests with shareholder value.
- Vesting schedules and tax withholding practices are standard across publicly traded companies.
- Companies like Pfizer and Teva Pharmaceuticals, which operate in the same industry, also utilize similar equity-based compensation strategies.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 03/02/2021 | Initial grant date of performance restricted stock units (PRSUs) that vested on March 2, 2024. |
| 03/02/2021 | Initial grant date of restricted stock units (RSUs) that vested in part on March 2, 2024. |
| 03/02/2022 | RSUs granted on March 2, 2021 vested. |
| 03/02/2023 | RSUs granted on March 2, 2021 vested. |
| 03/03/2023 | Initial grant date of restricted stock units (RSUs) that vested in part on March 3, 2024. |
| 03/04/2022 | Initial grant date of restricted stock units (RSUs) that vested in part on March 4, 2024. |
| 03/02/2024 | Vesting and settlement of performance restricted stock units (PRSUs) and restricted stock units (RSUs). |
| 03/03/2024 | Vesting and settlement of restricted stock units (RSUs). |
| 03/04/2024 | Vesting and settlement of restricted stock units (RSUs). |
| 03/04/2024 | Grant date of 70,085 restricted stock units (RSUs). |
| 03/05/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.